Microclinic Social Network Behavioral Health Trial in Jordan

NCT01818674 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 914

Last updated 2024-02-01

No results posted yet for this study

Summary

This 3-armed randomized controlled trial aims to evaluate the effectiveness of The Microclinic Behavioral Health Program in improving obesity and diabetes risk factors through a behavioral intervention program structured to enhance and promote social-network interactions and social support. The full version of the Microclinic Behavioral Health Program (Full MCP) with program-activated social-network interactions-with shared access to diabetes education, technology, and group support to promote weight and metabolic control through diet, exercise, medication adherence, and blood pressure management. Participants play a role in the collective effort to combat diabetes and solidifying self-management behavioral skills through peer-monitoring and encouragement of lifestyle behaviors. The study may yield valuable information on the impact of social support and social network interactions for enhancing body weight and blood sugar control. We compare the full MCP intervention, to a basic MCP intervention with more limited classroom interaction, and to an parallel monitoring control arm. And we aim to understand how metabolic changes over time relate to the cross-propagation of health behaviors between persons in social networks.

This Microclinic Behavioral Health Program was established in collaboration with the Royal Health Awareness Society (RHAS) and the Jordanian Ministry of Health (MoH).

Conditions

  • Diabetes Mellitus, Type 2
  • Obesity
  • Hypertension
  • Hyperglycemia
  • Blood Pressure
  • Hyperglycaemia (Diabetic)
  • Body Weight
  • Weight Loss
  • Weight, Body
  • Weight Change Trajectory
  • Weight Change, Body
  • Weight Gain
  • Blood Pressure, High
  • Social Behavior
  • Behavior, Health
  • Lifestyle Risk Reduction
  • Lifestyle, Healthy
  • Diabetes
  • Diabetes Mellitus
  • Glucose, High Blood

Interventions

BEHAVIORAL

Microclinic Behavioral Health Full Program (education curriculum in classroom setting, plus full social interaction program)

A 6-month intervention program (sessions and educational materials) aims to increase knowledge and skills in diabetes self-management and peer support and monitoring. The curriculum include causes of diabetes, prevention of complications, symptoms, self-management strategies, diet, exercise, peer monitoring and support by trained Project nurses from MoH health centers, local physicians, and university professors. Each class will provide 2-3 hours of discussion to foster active class participation and engagement.

BEHAVIORAL

Microclinic Behavioral Health Basic Program (education-only in classroom setting; no structured social interactions)

This basic program (6 month) aims to increase participants knowledge about diabetes self-management, but without structured social interaction programming. While group classroom setting is still used for delivery of the educational curriculum, the education program in group B have no group-based or team-building activities, group goal setting, and classroom program is lecture style with more limited class participation and interaction.

Sponsors & Collaborators

  • Royal Health Awareness Society (RHAS)

    collaborator UNKNOWN
  • Jordanian Ministry of Health (MoH)

    collaborator UNKNOWN
  • Microclinic International

    lead OTHER

Principal Investigators

  • Daniel E Zoughbie, D.Phil. · Microclinic International

  • Eric L Ding, Sc.D. · New England Complex Systems Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2016-06-30
Completion
2019-10-31

Countries

  • Jordan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01818674 on ClinicalTrials.gov